No Evidence of PGRN or MAPT Gene Dosage Alterations in a Collection of Patients with Frontotemporal Lobar Degeneration

Publisher： Karger

E-ISSN： 1421-9824|28|5|456-460

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.28, Iss.5, 2009-11, pp. : 456-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Absence of TARDBP Gene Mutations in an Italian Series of Patients with Frontotemporal Lobar Degeneration

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 3, 2009-09 ,pp. : 239-243

Karger

Access to resources Recommend Favorite

The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 5, Iss. 1, 2015-04 ,pp. : 147-154

Karger

Access to resources Recommend Favorite

Epidemiology of Frontotemporal Lobar Degeneration

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 4, 2004-06 ,pp. : 265-268

Karger

Access to resources Recommend Favorite

Patterns of Referring of Patients with Frontotemporal Lobar Degeneration to Psychiatric In- and Out-Patient Services

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 4, 2004-06 ,pp. : 269-273

Karger

Access to resources Recommend Favorite

Efficacy of Fluvoxamine as a Treatment for Behavioral Symptoms in Frontotemporal Lobar Degeneration Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 3, 2004-03 ,pp. : 117-121

Karger

Access to resources Recommend Favorite